2019新型冠状病毒核酸检测专家共识

2020-04-07 中华医学会检验医学分会 中华医学杂志.2020, 100(13):968-973.

突发新型冠状病毒肺炎疫情以来,感染病例快速上升。随着疫情的发展,全国各地乃至境外均有病例报道。及时对急重症及疑似患者进行诊断需要快速有效的方法,2019 新型冠状病毒(2019 novel coron

中文标题:

2019新型冠状病毒核酸检测专家共识

发布日期:

2020-04-07

简要介绍:

突发新型冠状病毒肺炎疫情以来,感染病例快速上升。随着疫情的发展,全国各地乃至境外均有病例报道。及时对急重症及疑似患者进行诊断需要快速有效的方法,2019 新型冠状病毒(2019 novel coronavirus,2019‑nCoV)核酸检测为诊断提供了直接证据。核酸检测过程中,因对病原体的传染途径和致病力尚未完全明确,工作人员存在较大的感染风险。此外,因为2019‑nCoV基因结构与一般RNA差别较大,所以检验流程、检验质量和生物安全均需要进行有效地规范。本共识在参阅国家卫生健康委员会相关文件、查阅文献、咨询重疫区相关专家的基础上进行编写,以对实验室检测工作提出有指导性的建议。本共识适用于从事2019‑nCoV核酸检测的所有实验室。

下载附件:

(因为版权问题,不支持下载)

评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=972519, encodeId=087a9e2519a9, content=棒棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/KbC410CniaDHx422zeY8c54ibCJOFj7oBa6J9nvp1TeRiaWuVGbWdu6PUW4bwnfs1umZVdvYU9JLvXuXqf37EdWIQ/132, createdBy=54672480577, createdName=zsq101, createdTime=Thu Jun 10 15:24:07 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964131, encodeId=e08f964131df, content=学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210224/47df305b8bd84d86b921cb8c9cd90017/e0068ffdf41846f5b5218c52b2a3467a.jpg, createdBy=12505184427, createdName=416韦祎, createdTime=Sun May 09 23:28:45 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963458, encodeId=347196345824, content=已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61895446793, createdName=ms1000000680052095, createdTime=Fri May 07 19:22:08 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918447, encodeId=326e91844e2c, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210120/129595ce5b304e3eb678614159341d44/d0c49877d8f440dcb741b90afaee8d29.jpg, createdBy=f0875411353, createdName=ms3000001402467596, createdTime=Wed Jan 20 15:55:07 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
    2021-06-10 zsq101

    棒棒

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=972519, encodeId=087a9e2519a9, content=棒棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/KbC410CniaDHx422zeY8c54ibCJOFj7oBa6J9nvp1TeRiaWuVGbWdu6PUW4bwnfs1umZVdvYU9JLvXuXqf37EdWIQ/132, createdBy=54672480577, createdName=zsq101, createdTime=Thu Jun 10 15:24:07 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964131, encodeId=e08f964131df, content=学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210224/47df305b8bd84d86b921cb8c9cd90017/e0068ffdf41846f5b5218c52b2a3467a.jpg, createdBy=12505184427, createdName=416韦祎, createdTime=Sun May 09 23:28:45 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963458, encodeId=347196345824, content=已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61895446793, createdName=ms1000000680052095, createdTime=Fri May 07 19:22:08 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918447, encodeId=326e91844e2c, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210120/129595ce5b304e3eb678614159341d44/d0c49877d8f440dcb741b90afaee8d29.jpg, createdBy=f0875411353, createdName=ms3000001402467596, createdTime=Wed Jan 20 15:55:07 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
    2021-05-09 416韦祎

    学习了!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=972519, encodeId=087a9e2519a9, content=棒棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/KbC410CniaDHx422zeY8c54ibCJOFj7oBa6J9nvp1TeRiaWuVGbWdu6PUW4bwnfs1umZVdvYU9JLvXuXqf37EdWIQ/132, createdBy=54672480577, createdName=zsq101, createdTime=Thu Jun 10 15:24:07 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964131, encodeId=e08f964131df, content=学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210224/47df305b8bd84d86b921cb8c9cd90017/e0068ffdf41846f5b5218c52b2a3467a.jpg, createdBy=12505184427, createdName=416韦祎, createdTime=Sun May 09 23:28:45 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963458, encodeId=347196345824, content=已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61895446793, createdName=ms1000000680052095, createdTime=Fri May 07 19:22:08 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918447, encodeId=326e91844e2c, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210120/129595ce5b304e3eb678614159341d44/d0c49877d8f440dcb741b90afaee8d29.jpg, createdBy=f0875411353, createdName=ms3000001402467596, createdTime=Wed Jan 20 15:55:07 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
    2021-05-07 ms1000000680052095

    已学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=972519, encodeId=087a9e2519a9, content=棒棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/KbC410CniaDHx422zeY8c54ibCJOFj7oBa6J9nvp1TeRiaWuVGbWdu6PUW4bwnfs1umZVdvYU9JLvXuXqf37EdWIQ/132, createdBy=54672480577, createdName=zsq101, createdTime=Thu Jun 10 15:24:07 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964131, encodeId=e08f964131df, content=学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210224/47df305b8bd84d86b921cb8c9cd90017/e0068ffdf41846f5b5218c52b2a3467a.jpg, createdBy=12505184427, createdName=416韦祎, createdTime=Sun May 09 23:28:45 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963458, encodeId=347196345824, content=已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61895446793, createdName=ms1000000680052095, createdTime=Fri May 07 19:22:08 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918447, encodeId=326e91844e2c, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210120/129595ce5b304e3eb678614159341d44/d0c49877d8f440dcb741b90afaee8d29.jpg, createdBy=f0875411353, createdName=ms3000001402467596, createdTime=Wed Jan 20 15:55:07 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
    2021-01-20 ms3000001402467596

    0

拓展阅读

新型冠状病毒感染的肺炎防控方案(第二版)

中华人民共和国国家卫生健康委员会 · 2020-01-22

新型冠状病毒感染的肺炎诊疗方案(试行第三版)

中华人民共和国国家卫生健康委员会 · 2020-01-23

预防 2019 年新型冠状病毒 (2019-nCoV) 传播给家庭和社区中其他人的暂行指南

美国疾病控制与预防中心(CDC,Centers for Disease Control and Prevention) · 2020-01-26

新型冠状病毒感染的肺炎诊疗方案(试行第五版)

中华人民共和国国家卫生健康委员会 · 2020-02-05